Petes to Receive Lifetime Achievement Award from Genetics Society of America
Tom Petes, the Minnie Geller Distinguished Professor of Research in Genetics in the School of Medicine and a Professor of Molecular Genetics and Microbiology, will be awarded the Lifetime Achieveme
A Fountain of Youth for the Brain
Wisdom may come with age, but young people have the advantage when it comes to learning. Duke neurobiologist Lindsey Glickfeld, Ph.D., wants to know why.
More to the point, she wants to know how. What are the mechanics in the brain and how do those mechanics change from childhood to adulthood?
What she discovers could one day help older people regain some ease of learning. Perhaps it could even lead to a treatment that could help stroke survivors relearn important early skills, like walking and talking.
Wilson Family Dedicates Nearly a Century to Duke
In a large academic medical system such as Duke, there are bound to be spouses, siblings or children who work for the same organization. Duke Health is fortunate enough to have one entire family who have dedicated a combined 83 years to improving the lives of their patients and colleagues.
Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate ivermectin at a higher dose for a longer period of time.
Evans Named a 2022 Sloan Research Fellow
Chantell Evans, PhD, an assistant professor of cell biology in the School of Medicine, has been selected to receive a 2022 Sloan Research Fellowship from the Alfred P. Sloan Foundation.
Robert M. Califf Confirmed as Commissioner for the US Food and Drug Administration
Robert M. Califf, MD, Duke University adjunct professor of medicine (cardiology) and former director of the Duke Clinical Research Institute (DCRI), has been confirmed as commissioner for the U.S. Food and Drug Administration following a vote by the Senate.
Vaccines and Immunology: Learning the Pandemic’s Lessons
Duke’s long leadership in vaccine research and the Duke Human Vaccine Institute’s (DHVI) dogged 25-year pursuit of answers to HIV put the university and health system in an excellent position to address the sudden, global challenge of the novel RNA coronavirus SARS-Cov-2 when it began to sweep around the world in 2020.
Women’s Reproductive Health: Addressing Challenges from COVID to Delivering Care in Under-served Areas
Women’s reproductive health encompasses a continuum of a woman’s lifespan. Five Duke experts addressed a number of these topics on Feb. 2 as a part of Research Week 2022.
Community Engagement/Health Disparities: How Researchers Can Combat Racism, Health Inequities
The COVID-19 pandemic has exacerbated pre-existing health inequities and emphasized the need for community-engaged research to address those disparities, according to a panel of Duke and UNC-Chapel Hill experts.